1.
Atalay S, van der Schoot LS, Vandermaesen L, van Vugt LJ, Eilander M, van den Reek JM, et al. Evaluation of a One-step Dose Reduction Strategy of Adalimumab, Etanercept and Ustekinumab in Patients with Psoriasis in Daily Practice. Acta Derm Venereol [Internet]. 2021 May 25 [cited 2025 Feb. 16];101(5):adv00463. Available from: https://medicaljournalssweden.se/actadv/article/view/699